Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive Patients
- 17 July 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (3) , 286-291
- https://doi.org/10.1161/01.cir.104.3.286
Abstract
Background We investigated whether serum concentration of carboxy-terminal propeptide of procollagen type I (PIP), a marker of collagen type I synthesis, can be used to assess the ability of antihy...Keywords
This publication has 11 references indexed in Scilit:
- Cardiac interstitium in health and disease: The fibrillar collagen networkPublished by Elsevier ,2010
- Fibrosis and hypertensive heart diseaseCurrent Opinion in Cardiology, 2000
- Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive ratsJournal Of Hypertension, 1999
- How to diagnose diastolic heart failureEuropean Heart Journal, 1998
- Changes of Plasma Endothelin and Growth Factor Levels, and of Left Ventricular Mass, After Chronic AT1-Receptor Blockade in Human HypertensionAmerican Journal of Hypertension, 1998
- Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarctionCardiovascular Research, 1997
- Monitoring fibrillar collagen turnover in hypertensive heart diseaseCardiovascular Research, 1997
- Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive ratsAmerican Journal of Hypertension, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Ventricular Arrhythmias in Hypertensive Left Ventricular HypertrophyAmerican Journal of Hypertension, 1990